Abiosciences
PrivateLast Round
Series A++
May 25, 2021
Company Overview
Abiosciences is a biotechnology company that provides single-cell genomic sequencing, bioinformatics analysis, and therapeutic target discovery services for the life sciences and pharmaceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics, Data Visualization
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abiosciences Comparables
Compare Abiosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scailyte AG | 87% | |
| One Biosciences | 83% | |
| Ozette | 80% |
Abiosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A++ | May 25, 2021 | ||||
| Strategic | Feb 1, 2021 | ||||
| Series A Extension | Dec 29, 2020 | ||||
| Series A | Jun 1, 2019 |
Abiosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series A Extension, Series A++, Series A |
| Primavera Venture Partners | Series A++ |
| 松禾资本 (Green Pine Capital Partners) | Series A++ |
| HongShan Capital Group (HSG) | Series A++ |
| SB China Capital | Series A Extension |
| Apricot Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2021
Led by HongShan Capital Group (HSG) with participation from Primavera Venture Partners, IDG Capital, and Green Pine Capital Partners.
Abiosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Abiosciences's valuation, stock price, and market status.
Is Abiosciences a public or private company?
Abiosciences is a private company.
What is the current stock price of Abiosciences?
Abiosciences is a private company with no public stock price. Caplight tracks Abiosciences's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Abiosciences worth (valuation)?
Valuation information for Abiosciences is not publicly available.
Can I buy Abiosciences stock?
Abiosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Abiosciences's last funding round?
Abiosciences's most recent funding round was Series A++ on May 25, 2021.
Who are the main investors in Abiosciences?
Key investors in Abiosciences include IDG Capital, HongShan, SB China Capital.
Will Abiosciences IPO soon?
No public IPO plans have been announced for Abiosciences.
How can I track Abiosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Abiosciences's secondary market activity and sign up for updates.